Circulating long non-coding RNA H19 as a novel biomarker for right ventricular failure associated with pulmonary arterial hypertension
Circulating long non-coding RNA H19 as a novel biomarker for right ventricular failure associated with pulmonary arterial hypertension
批准号:
411863
负责人:
Omura Junichi
金额:
$0.07万
依托单位国家:
加拿大
项目类别:
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-09-01 至 2020-09-01
关键词:
中文摘要
背景:右心室衰竭(RVF)是肺动脉高压(PAH)的主要不良预后因素。最近的组学分析表明,长链非编码rna (LncRNAs)在心血管疾病中的失调。此外,circulati
英文摘要
Background: Right ventricular failure (RVF) is a major adverse prognostic factor in pulmonary arterial hypertension (PAH). Recent Omics analyses demonstrated the deregulation of long non-coding RNAs (LncRNAs) in cardiovascular disease. Moreover, circulati
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Long Noncoding RNA H19 in the pathogenesis of Right Ventricular Failure associated with Pulmonary Arterial Hypertension -A Putative Novel Biomarker and Therapeutic Target-
-
批准号:391721
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2018
-
负责人:Omura Junichi
-
依托单位: